FDA Approves Axatilimab for Chronic GVHD ...Middle East

The first-in-class treatment for chronic graft-versus-host disease is indicated for adult and pediatric patients weighing at least 40 kg. Medscape Medical News

Hence then, the article about fda approves axatilimab for chronic gvhd was published today ( Thursday 15/08/2024 - 12:36 AM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves Axatilimab for Chronic GVHD )

Also on site :

• ‘The Young and the Restless’ Legend Eileen Davidson Reveals How One ‘Topical’ Storyline Literally Saved Fans’ Lives (Exclusive)
• Palantir touts record expansion and ‘battlefield’ AI value
• Iran war live: Washington, Tehran trade threats over Strait of Hormuz